Lymphoma Extranodal Nk-t-cell
📧 Sign up to get email alerts when something new happens for Lymphoma Extranodal Nk-t-cell.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas [Phase 1]
Phase 1 clinical trial evaluating T cells expressing a fully-human anti-CD30 CAR for CD30-expressing lymphomas; study completed with posted …
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY] [Phase 2]
Phase 2 clinical trial update for avelumab in relapsed or refractory extranodal NK/T-cell lymphoma (ENKTL).